Log in to save to my catalogue

Discovery of Mcl-1-specific inhibitor AZD5991 and preclinical activity in multiple myeloma and acute...

Discovery of Mcl-1-specific inhibitor AZD5991 and preclinical activity in multiple myeloma and acute...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_814ff3ef6b204d84917e2b025f3e1da9

Discovery of Mcl-1-specific inhibitor AZD5991 and preclinical activity in multiple myeloma and acute myeloid leukemia

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Mcl-1 is a member of the Bcl-2 family of proteins that promotes cell survival by preventing induction of apoptosis in many cancers. High expression of Mcl-1 causes tumorigenesis and resistance to anticancer therapies highlighting the potential of Mcl-1 inhibitors as anticancer drugs. Here, we describe AZD5991, a rationally designed macrocyclic mole...

Alternative Titles

Full title

Discovery of Mcl-1-specific inhibitor AZD5991 and preclinical activity in multiple myeloma and acute myeloid leukemia

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_814ff3ef6b204d84917e2b025f3e1da9

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_814ff3ef6b204d84917e2b025f3e1da9

Other Identifiers

ISSN

2041-1723

E-ISSN

2041-1723

DOI

10.1038/s41467-018-07551-w

How to access this item